TriSalus Life Sciences (TLSI) EBIT (2021 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly EBIT of -$8.4 million for Q1 2026, down 14.76% year-over-year from -$9.9 million in Q1 2025, and down 157.14% quarter-over-quarter from -$3.3 million in Q4 2025.
TriSalus Life Sciences (TLSI) EBIT (2021 - 2026) Analysis & Trends
TriSalus Life Sciences' EBIT history runs 6 years deep, the most recent figure standing at -$8.4 million for Q1 2026.
- In Q1 2026, EBIT fell 14.76% year-over-year to -$8.4 million; the TTM figure through Mar 2026 stood at -$28.0 million (up 11.92% YoY), while the FY2025 annual figure was -$26.9 million, up 25.49% from the prior year.
- EBIT for Q1 2026 stood at -$8.4 million, down from -$3.3 million in the prior quarter.
- The five-year high for EBIT was -$288273.0 in Q2 2022, with the low at -$18.6 million in Q3 2023.
- The 5-year median for EBIT is -$8.4 million (2026), against an average of -$8.6 million.
- The sharpest annual moves came in 2022 and 2023: EBIT soared 63.23% in 2022, then sank 3866.38% in 2023.
- TriSalus Life Sciences' EBIT stood at -$11.8 million in 2022, then declined by 21.03% to -$14.2 million in 2023, then jumped by 46.8% to -$7.6 million in 2024, then soared by 56.85% to -$3.3 million in 2025, then plunged by 157.14% to -$8.4 million in 2026.
- Business Quant data shows TLSI's EBIT at -$8.4 million in Q1 2026, -$3.3 million in Q4 2025, and -$9.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 285.80 Mn |
| 10 | TriSalus Life Sciences | 307.81 Mn | 261.52 Mn | 9.90 Mn | -9.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.81 Mn |
| Mar 31, 2026 | -8.41 Mn |
| Dec 31, 2025 | -3.27 Mn |
| Sep 30, 2025 | -9.01 Mn |
| Jun 30, 2025 | -7.33 Mn |
| Mar 31, 2025 | -7.33 Mn |
| Dec 31, 2024 | -7.58 Mn |
| Sep 30, 2024 | -8.74 Mn |
| Jun 30, 2024 | -8.17 Mn |
| Mar 31, 2024 | -11.67 Mn |
| Dec 31, 2023 | -14.25 Mn |
| Sep 30, 2023 | -18.62 Mn |
| Jun 30, 2023 | -11.43 Mn |
| Mar 31, 2023 | -10.12 Mn |
| Dec 31, 2022 | -11.77 Mn |
| Sep 30, 2022 | -8.11 Mn |
| Jun 30, 2022 | -288,273.00 |
| Mar 31, 2022 | -669,807.00 |
| Dec 31, 2021 | -1.14 Mn |
| Sep 30, 2021 | -807,259.00 |